martes, 25 de octubre de 2016

Prostate Cancer Treatment (PDQ®)—Health Professional Version - National Cancer Institute

Prostate Cancer Treatment (PDQ®)—Health Professional Version - National Cancer Institute

Instituto Nacional Del Cáncer

Prostate Cancer Treatment (PDQ®)–Health Professional Version


Changes to This Summary (10/21/2016)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added text to include hormonal manipulations with chemotherapy as a new standard treatment option.
Revised text to state that in the CHAARTED trial, 790 patients with metastatic, hormone-sensitive disease were randomly assigned to receive androgen deprivation therapy with or without docetaxel.
Added Hormonal manipulations with chemotherapy as a new subsection.
Added Immediate Versus Deferred Hormonal Therapy as a newly titled and revised subsection.
This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
  • Updated: October 21, 2016

No hay comentarios:

Publicar un comentario